Table 2 Measurements of the time to blood stage patency indicate that there is no loss of infectivity with purified P. yoelii sporozoites
From: A rapid and scalable density gradient purification method for Plasmodium sporozoites
Type | Replicate # | # Sporozoites injected | # Mice infected | # Mice patent (Day of patency) |
|---|---|---|---|---|
Unpurified | 1 | 10,000 | 5 | 5 (3d) |
| Â | 2 | 10,000 | 5 | 5 (3d) |
| Â | 1 | 1,000 | 5 | 5 (4d) |
| Â | 2 | 1,000 | 5 | 5 (4d) |
Purified | 1 | 10,000 | 5 | 5 (3d) |
| Â | 2 | 10,000 | 5 | 5 (3d) |
| Â | 1 | 1,000 | 5 | 5 (4d) |
| Â | 2 | 1,000 | 5 | 5 (4d) |